Nova Bright Skin SPF 30

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Nova Bright Skin SPF 30
Generic name
OCTINOXATE, HOMOSALATE, OCTISALATE, OXYBENZONE, AVOBENZONE
Manufacturer
Innovation Brands Inc.
Product type
HUMAN OTC DRUG
SPL set ID
1c201147-7a54-41b5-bdf0-394e3d7efc0c
SPL ID
5a9283f7-8be2-4f48-bf51-bcfadb76ad7b
Version
4
Effective date
2025-07-01
Source export date
2026-09-28
Source partition
8
Source file
https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/ae3816359e336a5de4f44607730a3d12ceb61ffa012a132189ceda22541b38ee/drug-label-0008-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 05:55:58
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Do not use on damaged or broken skin. Keep out of eyes. If contact occurs, rinse with water. If rash or irritation develops, discontinue use and consult your physician. Stop using this product and ask doctor if rash or redness develops and lasts. Keep out of reach of children. If accidental ingestion, call the Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.